Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

178
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
178
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

140
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
140
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

324
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
324
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

226
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
226

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Thermally air oxidation of activated carbon for enhanced lead(II) removal with preliminary insights into CO<sub>2</sub> and <sup>222</sup>radon adsorption.

Environmental science and pollution research international·2026
Same author

Electrochemical biosensors: a novel approach for rapid and cost-effective hCG monitoring in gestational trophoblastic tumours.

RSC advances·2026
Same author

High-sensitivity electrochemical immunosensor for anti-SARS-CoV-2 IgG detection using screen-printed carbon/cerium oxide-gold electrode.

ADMET & DMPK·2026
Same author

Graphene-supported Pd/Pt nano-catalysts for enhanced colorimetric detection of dopamine and NADH using paper-based microfluidic devices.

ADMET & DMPK·2026
Same author

Advances in biosensor technologies for early diagnosis of preeclampsia through molecular biomarkers.

Methods (San Diego, Calif.)·2026
Same author

The Effect of Variations in Temperature and Contact Time of Zingerone, [6]-Gingerol and Shogaol as Disinfectants on <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i> and <i>Candida albicans</i>.

Microorganisms·2026

相关实验视频

Updated: Jun 27, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K

多种耐药结核病的多种药物耐药性结核病.

Dika Apriliana Wulandari1, Yeni Wahyuni Hartati1, Abdullahi Umar Ibrahim2

  • 1Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km 21, 45363, Indonesia.

Clinica chimica acta; international journal of clinical chemistry
|May 2, 2024
PubMed
概括

结核病 (TB) 是全球主要的健康威胁. 快速分子检测多药耐药结核病 (MDR-TB) 对于打击其传播和降低死亡率至关重要.

关键词:
检测MDR-TB的检测方法多种耐药结核病的多种药物耐药性结核病.结核病生物标志物 结核病生物标志物结核病是一种疾病.

更多相关视频

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K

相关实验视频

Last Updated: Jun 27, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K

科学领域:

  • 微生物学 微生物学
  • 传染性疾病 传染性疾病
  • 遗传学 是一个遗传学.

背景情况:

  • 由Mycobacterium tuberculosis (MTB) 引起的结核病 (TB) 是全球死亡的主要原因.
  • 不充分的治疗可以促进耐药性,而多耐药性结核病 (MDR-TB) 是一个重大问题.
  • 多抗药性结核病源于rpoB和katG基因的突变,使其对利芬素 (RIF) 和异化 (INH) 产生耐药性.

研究的目的:

  • 审查用于检测MDR-TB的生物标志物.
  • 讨论抗结核病药物和产生耐药性的突变.
  • 突出快速MDR-TB诊断的需要,以减少全球发病率和死亡率.

主要方法:

  • 关于MDR-TB诊断的文献审查.
  • 用于MTB检测的生物标志物的分类.
  • 分析与耐药性相关的遗传突变.

主要成果:

  • 结核病诊断的传统培养方法是缓慢的.
  • 分子技术为检测MDR-TB提供了敏感和特定的替代方案.
  • 特定的基因突变 (rpoB,katG) 与对关键抗结核药物的耐药性有关.

结论:

  • 快速准确地检测MDR-TB对于有效的治疗和控制至关重要.
  • 分子诊断对于对MDR-TB的及时干预至关重要.
  • 减少MDR-TB发病率需要加强诊断策略和意识.